Ikarian Capital’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.24M | Buy |
+198,528
| New | +$2.24M | 0.43% | 38 |
|
|
2023
Q4 | – | Sell |
-142,692
| Closed | -$1.37M | – | 100 |
|
|
2023
Q3 | $1.37M | Buy |
142,692
+2,692
| +2% | +$25.9K | 0.17% | 41 |
|
|
2023
Q2 | $1.26M | Hold |
140,000
| – | – | 0.2% | 44 |
|
|
2023
Q1 | $1.1M | Buy |
+140,000
| New | +$1.1M | 0.25% | 50 |
|
|
2022
Q2 | – | Sell |
-39,730
| Closed | -$586K | – | 128 |
|
|
2022
Q1 | $586K | Buy |
39,730
+3,154
| +9% | +$46.5K | 0.08% | 88 |
|
|
2021
Q4 | $484K | Sell |
36,576
-60,000
| -62% | -$794K | 0.07% | 98 |
|
|
2021
Q3 | $1.69M | Sell |
96,576
-389
| -0.4% | -$6.79K | 0.12% | 74 |
|
|
2021
Q2 | $2.32M | Sell |
96,965
-200,000
| -67% | -$4.79M | 0.19% | 76 |
|
|
2021
Q1 | $7.63M | Sell |
296,965
-766,996
| -72% | -$19.7M | 0.26% | 27 |
|
|
2020
Q4 | $20.2M | Sell |
1,063,961
-171,510
| -14% | -$3.26M | 0.89% | 3 |
|
|
2020
Q3 | $15.6M | Buy |
1,235,471
+122,076
| +11% | +$1.54M | 1.13% | 2 |
|
|
2020
Q2 | $13.5M | Buy |
1,113,395
+166,790
| +18% | +$2.02M | 1.07% | 7 |
|
|
2020
Q1 | $7.24M | Buy |
946,605
+734,185
| +346% | +$5.62M | 0.54% | 15 |
|
|
2019
Q4 | $3.78M | Buy |
+212,420
| New | +$3.78M | 0.61% | 9 |
|